Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
80 81 Next >
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
From Everest Medicines Limited
Via ACN Newswire
eBRAM Partners with Agency for Volunteer Service to Launch 'Pro-Bono Online Mediation Scheme for Water Seepage Disputes'
Via ACN Newswire
Advancing the Belt and Road Initiative: The Kyrgyz Republic Ministry of Finance's First Promotional Seminar and Non-Deal Roadshow Successfully Held
Via ACN Newswire
Machine learning used to optimise polymer production
From Science and Technology of Advanced Materials
Via ACN Newswire
CleverTap Report: 46% of Product Managers Cite Resource Limitations as Top Barrier to App and Web Experimentation
From CleverTap
Via ACN Newswire
Tickers PZZA
Spritzer Clinches 10th Consecutive "Brand of the Year" Award at the World Branding Awards in London
From Spritzer Bhd
Via ACN Newswire
Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong
From Everest Medicines Limited
Via ACN Newswire
Edvantage Group Announces FY2024 Annual Results
From Edvantage Group Holdings Limited
Via ACN Newswire
The Hong Kong Institute of Directors Announces Winners
From The Hong Kong Institute of Directors (HKIoD)
Via ACN Newswire
NEFECON(R) Included in National Reimbursement Drug List (NRDL)
Via ACN Newswire
NaaS Turns a Profit, but Challenges Loom in the EV Charging Race
Via ACN Newswire
Tickers NAAS
Dmall Inc. Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
From Dmall Inc.
Via ACN Newswire
Niyo Doubles Click-Through Rates and Improves Customer Retention with CleverTap
From CleverTap
Via ACN Newswire
Tickers TD TDBCP
SCIB Reports 14.6% Revenue Growth to RM45.1 Million in Q1FY2025
From Sarawak Consolidated Industries Bhd
Via ACN Newswire
LANGHAM BEAUTY Green Vitality
From Champion REIT
Via ACN Newswire
Tickers CMPNF
Cropmate Berhad IPO Oversubscribed by 84.88 Times
From Cropmate Berhad
Via ACN Newswire
Survey: New Opportunities in Cross-border E-commerce
From HKTDC
Via ACN Newswire
SF Holding successfully listed in Hong Kong
Via ACN Newswire
Kingworld-Longde Life and Health Industrial Park Grand Opening
From Kingworld Medicines Group
Via ACN Newswire
Swire Coca-Cola Hong Kong Leverages SAP S/4HANA and SAP Services to Drive Digital Transformation
From SAP HK
Via ACN Newswire
Tickers SAP
RichTech Digital Berhad Signs Underwriting Agreement with KAF Investment Bank Berhad
From RichTech Digital Berhad
Via ACN Newswire
Ching Lee Holdings (3728.HK) Reports Significant Growth in Interim Results for 2024
From Ching Lee Holdings Limited
Via ACN Newswire
Genetec maintains stable and profitable performance on a lower Q1FY2025 revenue
From Genetec Technology Bhd
Via ACN Newswire
Grand Ming Group Announces Interim Results for the Six Months Ended 30 September 2024
From Grand Ming Group Holdings Limited
Via ACN Newswire
EdgePoint Infrastructure Inks Strategic Partnership with CelcomDigi to expand connectivity in Malaysia at TowerXchange Meet Up Asia 2024
From EdgePoint
Via ACN Newswire
Propel Global Reports Encouraging 24.2% Growth in Revenue to RM34.3 Million in Q1 FY2025
From Propel Global Bhd
Via ACN Newswire
TOPVISION Launches Prospectus for the Transfer of Listing from the LEAP Market to ACE Market
From TOPVISION Eye Specialist Berhad
Via ACN Newswire
KOSPET Launches M3 Ultra and T3 Ultra Rugged Smartwatches in Malaysia, Redefining Durability and Innovation
From KOSPET
Via ACN Newswire
S&P Acknowledges Fosun's Return to the USD Bond Market
Via ACN Newswire
Tickers FOSUF FOSUY
New Progress in the Merger of Guotai Junan and Haitong Securities
Via ACN Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
80 81 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.